Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis-Reference-Cited by-同舟云学术

Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis

Published:2016-08 Issue:8 Volume:4 Page:e568-e578
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Nayagam Shevanthi,Conteh Lesong,Sicuri Elisa,Shimakawa Yusuke,Suso Penda,Tamba Saydiba,Njie Ramou,Njai Harr,Lemoine Maud,Hallett Timothy B,Thursz Mark

Publisher

Elsevier BV

Subject

General Medicine

Reference70 articles.

1. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013;Schweitzer;Lancet,2015

2. 20 years into the Gambia Hepatitis Intervention Study: assessment of initial hypotheses and prospects for evaluation of protective effectiveness against liver cancer;Viviani;Cancer Epidemiol Biomarkers Prev,2008

3. Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries;Dan;Hepatol Int,2014

4. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country;Toy;Eur J Health Econ,2012

5. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening;Hahne;BMC Infect Dis,2013

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Costs of Community-Based Viral Hepatitis Screening in Cameroon Using Point-of-Care Technologies;Open Forum Infectious Diseases;2024-06-28

2. Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection;The Lancet Gastroenterology & Hepatology;2024-04

3. Cost-effectiveness of a pediatric operating room installation in Sub-Saharan Africa;PLOS Global Public Health;2024-03-27

4. Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis;The Lancet Global Health;2024-01

5. Virological, serological and clinical outcomes in chronic hepatitis B virus infection: development and validation of the HEPA-B simulation model;BMJ Open;2024-01